OCGN 8-K 2026-11-10

Ocugen, Inc. (OCGN) 8-K dated 2026-11-10 — accession 0001104659-26-124836.

Ocugen, Inc. (OCGN) is a biotechnology company listed on NASDAQ.

Ocugen, Inc. filed a 8-K on 2026-11-10. Accession 0001104659-26-124836.

This 8-K covers: Material agreement (Item 1.01), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported OCGN revenue for 2026-06-30 was $1.5M. Net income was -$24.9M. Revenue was down 2.9% from 2026-03-31 to 2026-06-30. OCGN currently screens at market cap $416.4M.

Not investment advice. The OCGN SEC hub lists recent forms. The stock page is the research view.